Stellenwert der Stammzelltherapie in der Behandlung der Harninkontinenz

Harninkontinenz ist sowohl für Frauen als auch für Männer ein sehr belastendes Krankheitsbild. Chirurgische Therapieoptionen sind häufig komplikationsträchtig und nicht bei allen Patienten erfolgreich. Der Einsatz von Stammzellen zur Behandlung der Harninkontinenz erscheint vielversprechend. Dieser Beitrag stellt die Ergebnisse tierexperimenteller und erster klinischer Studien zur Stammzelltherapie vor.

• Literatur

• 1 Chong EC, Anger JT. The financial burden of stress urinary incontinence among women in the United States. Curr Urol Rep 2011; 12: 358-362
• 2 Levy R, Muller N. Urinary incontinence: economic burden and new choices in pharmaceutical treatment. Adv Ther 2006; 23: 556-573
• 3 Farage MA, Miller KW, Berardesca E. et al. Psychosocial and societal burden of incontinence in the aged population: a review. Arch Gynecol Obstet 2008; 277: 285-290
• 4 Wilson L, Brown JS, Shin GP. et al. Annual direct cost of urinary incontinence. Obstet Gynecol 2001; 98: 398-406
• 5 Abrams P, Cardozo L, Fall M. et al. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn 2002; 21: 167-178
• 6 Norton P, Brubaker L. Urinary incontinence in women. Lancet 2006; 367: 57-67
• 7 Corcos J, Beaulieu S, Donovan J. et al. Quality of life assessment in men and women with urinary incontinence. J Urol 2002; 168: 896-905
• 8 Danforth KN, Townsend MK, Lifford K. et al. Risk factors for urinary incontinence among middle-aged women. Am J Obstet Gynecol 2006; 194: 339-345
• 9 Ruiz-Zapata A, Feola A, Heesakkers J. et al. Biomechanical Properties of the Pelvic Floor and its Relation to Pelvic Floor Disorders. European Urology Supplements 2018; 17: 80-90
• 10 Sajadi KP, Gill BC, Damaser MS. Neurogenic aspects of stress urinary incontinence. Curr Opin Obstet Gynecol 2010; 22: 425-429
• 11 McGuire E, Lytton B, Pepe V. et al. Stress Urinary Incontinence. Obstet Gynecol 1976; 47: 255-264
• 12 Kayigil O, Ahmed I, Metin A. The coexistence of intrinsic sphincter deficiency with type II stress incontinence. J Urol 1999; 16: 1365-1366
• 13 Magon N, Kalra B, Malik S. et al. Stress urinary incontinence: What, when, why, and then what?. J Midlife Health 2011; 2: 57-64
• 14 Dumoulin C, Cacciari LP, Hay-Smith EJC. Pelvic floor muscle training versus no treatment, or inactive control treatments, for urinary incontinence in women. Cochrane Database Syst Rev 2018; (10) CD005654
• 15 Berghmans LC, Hj H, Bo K. et al. Conservative treatment of stress urinary incontinence in women: a systematic review of randomized clinical trials. Br J Urol 1998; 82: 181-191
• 16 Sievert KD, Abufaraj M, Kernig K. et al. Sling Surgery for Female Incontinence. European Urology Supplements 2018; 17: 109-118
• 17 Kobashi KC, Albo ME, Dmochowski RR. et al. Surgical Treatment of Female Stress Urinary Incontinence: AUA/SUFU Guideline. J Urol 2017; 198: 875-883
• 18 Brubaker L, Albo ME, Chai TC. et al. Adverse events over two years after retropubic or transobturator midurethral sling surgery: findings from the Trial of Midurethral Slings (TOMUS) study. Am J Obstet Gynecol 2011; 205: 498.e1-498.e6
• 19 Considerations about Surgical Mesh for SUI, FDA (aktuelles Update 06.06.2019). Online: https://www.fda.gov/medical-devices/urogynecologic-surgical-mesh-implants/considerations-about-surgical-mesh-sui Stand: 30.06.2019
• 20 FDA. UPDATE on serious complications associated with transvaginal placement of surgical mesh for pelvic organ prolapse: FDA safety communication. 2011. Online: http://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/ucm262435.htm Stand: 05.07.2015
• 21 Chang J, Lee D. Midurethral slings in the mesh litigation era. Transl Androl Urol 2017; 6 (Suppl. 02) S68-S75
• 22 Chapple CR, Cruz F, Deffieux X. et al. Consensus Statement of the European Urology Association and the European Urogynaecological Association on the Use of Implanted Materials for Treating Pelvic Organ Prolapse and Stress Urinary Incontinence. Eur Urol 2017; 72: 424-431
• 23 Kastelein AW, Dicker MFA, Opmeer BC. et al. Innovative Treatment Modalities for urinary incontinence: a European survey identifying experience and attitude of healthcare providers. Int Urogynecol J 2017; 28: 1725-1731
• 24 Thomas ED, Lochte jr. HL, Cannon JH. et al. Supralethal whole body irradiation and isologous marrow transplantation in man. J Clin Invest 1959; 38: 1709-1716
• 25 Welche Krankheiten können mit Stammzellen behandelt werden?. Online: https://www.eurostemcell.org/de/welche-krankheiten-koennen-mit-stammzellen-behandelt-werden Stand: 08.03.2019
• 26 National Institute of Health, US Department of Health and Human Services. NIH Stem Cell Information Home Page. In Stem Cell Information. 2016. Online: https://stemcells.nih.gov Stand: 19.03.2016
• 27 Thomson JA, Itskovitz-Eldor J, Shapiro SS. et al. Embryonic stem cell lines derived from human blastocysts. Science 1998; 282: 1145-1147
• 28 Hipp J, Atala A. Sources of stem cells for regenerative medicine. Stem Cell Review 2008; 4: 3-11
• 29 Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006; 126: 663-676
• 30 Cannon TW, Lee JY, Somogyi G. et al. Improved sphincter contractility after allogenic muscle-derived progenitor cell injection into the denervated rat urethra. Urology 2003; 62: 958-963
• 31 Advanced therapy medicinal products: Overview. Online: https://www.ema.europa.eu/en/human-regulatory/overview/advanced-therapy-medicinal-products-overview Stand: 08.03.2019
• 32 Kwon D, Minnery B, Kim Y. et al. Neurologic recovery and improved detrusor contractility using muscle-derived cells in rat model of unilateral pelvic nerve transection. Urology 2005; 65: 1249-1253
• 33 Hoshi A, Tamaki T, Tono K. et al. Reconstruction of Radical Prostatectomy-Induced Urethral Damage Using Skeletal Muscle-Derived Multipotent Stem Cells. Transplantation 2008; 85: 1617-1624
• 34 Mitterberger M, Pinggera GM, Marksteiner R. et al. Functional and Histological Changes after Myoblast Injections in the Porcine Rhabdosphincter. Eur Urol 2007; 52: 1736-1743
• 35 Eberli D, Aboushwareb T, Soker S. et al. Muscle Precursor Cells for the Restoration of Irreversibly Damaged Sphincter Function. Cell Transplantation 2012; 21: 2089-2098
• 36 Furuta A, Carr LK, Yoshimura N. et al. Advances in the understanding of sress urinary incontinence and the promise of stem-cell therapy. Rev Urol 2007; 9: 106-112
• 37 Williams JK, Dean A, Lankford S. et al. Determinates of muscle precursor cell therapy efficacy in a nonhuman primate model of intrinsic urinary sphincter deficiency. Stem Cell Res Ther 2017; 8: 1 doi:10.1186/s13287-016-0461-6
• 38 Williams JK, Dean A, Badra S. et al. Cell versus Chemokine Therapy in a Nonhuman Primate Model of Chronic Intrinsic Urinary Sphincter Deficiency. J Urol 2016; 196: 1809-1815 doi:10.1016/j.juro.2016.05.106
• 39 Forcales SV. Potential of adipose-derived stem cells in muscular regenerative therapies. Front Aging Neurosci 2015; 7: 123
• 40 Lin G, Wang G, Banie L. et al. Treatment of stress urinary incontinence with adipose tissue-derived stem cells. Cytotherapy 2010; 12: 88-95
• 41 Silwal Gautam S, Imamura T, Ishizuka O. et al. Implantation of autologous adipose-derived cells reconstructs functional urethral sphincters in rabbit cryoinjured urethra. Tissue Eng Part A 2014; 20: 1971-1979
• 42 Li Y, Green M, Wen Y. et al. Efficacy and Safety of Immuno-Magnetically Sorted Smooth Muscle Progenitor Cells Derived from Human-Induced Pluripotent Stem Cells for Restoring Urethral Sphincter Function. Stem Cells Transl Med 2017; 6: 1158-1167 doi:10.1002/sctm.16-0160
• 43 Li GY, Zhou F, Gong YQ. et al. Activation of VEGF and ERK1/2 and improvement of urethral function by adipose-derived stem cells in a rat stress urinary incontinence model. Urology 2012; 80: 953.e1-953.e8
• 44 Togel F, Westenfelder C. Adult bone marrow-derived stem cells for organ regeneration and repair. Dev Dyn 2007; 236: 3321-3331
• 45 Burdzinska A, Dybowski B, Zarychta-Wisniewska W. et al. Intraurethral co-transplantation of bone marrow mesenchymal stem cells and muscle-derived cells improves the urethral closure. Stem Cell Res Ther 2018; 9: 239
• 46 Sadeghi Z, Isariyawongse J, Kavran M. et al. Mesenchymal stem cell therapy in a rat model of birth-trauma injury: functional improvements and biodistribution. Int Urogynecol J 2016; 27: 291-300 doi:10.1007/s00192-015-2831-5
• 47 Zhou Y, Kang G, Wen Y. et al. Do Induced Pluripotent Stem Cell Characteristics Correlate with Efficient In Vitro Smooth Muscle Cell Differentiation? A Comparison of Three Patient-Derived Induced Pluripotent Stem Cell Lines. Stem Cells Dev 2018; 27: 1438-1448 doi:10.1089/scd.2018.0031
• 48 Chun SY, Kwon JB, Chae SY. et al. Combined injection of three different lineages of early-differentiating human amniotic fluid-derived cells restores urethral sphincter function in urinary incontinence. BJU Int 2014; 114: 770-783 doi:10.1111/bju.12815
• 49 Gluckman E, Rocha V, Boyer-Chammard A. et al. Outcome of cord-blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation Group. N Engl J Med 1997; 337: 373-381
• 50 Dissaranan C, Cruz M, Kiedrowski MJ. et al. Rat mesenchymal stem cell secretome promotes elastogenesis and facilitates recovery from simulated childbirth injury. Cell Transplant 2014; 23: 1395-1406
• 51 Deng K, Lin DL, Hanzlicek B. et al. Mesenchymal stem cells and their secretome partially restore nerve and urethral function in a dual muscle and nerve injury stress urinary incontinence model. Am J Physio Renal Physiol 2015; 308: F92-F100
• 52 Williams JK, Dean A, Badra S. et al. Cell versus Chemokine Therapy in a Nonhuman Primate Model of Chronic Intrinsic Urinary Sphincter Deficiency. J Urol 2016; 196: 1809-1815 doi:10.1016/j.juro.2016.05.106
• 53 Kuismanen K, Sartoneva R, Haimi S. et al. Autologous adipose stem cells in treatment of female stress urinary incontinence. Stem Cells Transl Med 2014; 3: 936
• 54 Stangel-Wojcikiewicz K, Jarocha D, Piwowar M. et al. Autologous muscle-derived cells for the treatment of female stress urinary incontinence: a 2-year follow-up of a Polish investigation. Neururol Urodyn 2014; 33: 324-330
• 55 Stangel-Wojcikiewicz K, Jach R, Majka M. et al. Quality of life assessment in female patients 2 and 4 years after muscle-derived cell transplants for stress urinary incontinence treatment. Ginekol Pol 2016; 87: 183-189
• 56 Sèbe P, Doucet C, Cornu JN. et al. Intrasphincteric injections of autologous muscular cells in women with refractory stress urinary incontinence: a prospective study. Int Urogynecol J 2011; 22: 183-189
• 57 Cornu JN, Lizée D, Pinset C. et al. Long-term follow-up after regenerative therapy of the urethral sphincter for female stress urinary incontinence. Eur Urol 2014; 65: 256-258
• 58 Blaganje M, Lukanović A. Intrasphincteric autologous myoblast injections with electrical stimulation for stress urinary incontinence. Int J Gynaecol Obstet 2012; 117: 164-167
• 59 Blaganje M, Lukanovic A. Ultra-sound-guided autologous myoblast injections into the extrinsic urethral sphincter: tissue engineering for the treatment of stress urinary incontinence. Int Urogynecol 2013; 24: 533-535
• 60 Carr LK, Kultgen PL, Herschorn S. et al. Autologous muscle derived cell therapy for stress urinary incontinence: a prospective, dose ranging study. J Urol 2014; 192: 469-476
• 61 Carr LK, Steele D, Steele S. et al. 1-year follow-up of autologous muscle-derived stem cell injection pilot study to treat stress urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct 2008; 19: 881-883
• 62 Peters KM, Dmochowski RR, Carr LK. et al. Autologous muscle derived cells for treatment of stress urinary incontinence in women. J Urol 2014; 192: 469-476
• 63 Jankowski RJ, Tu LM, Carlson C. et al. A double-blind, randomized, placebo-controlled clinical trial evaluating the safety and efficacy of autologous muscle derived cells in female subjects with stress urinary incontinence. Int Urol Nephrol 2018; 50: 2153-2165
• 64 Cryanoski D. Japanʼs approval of stem-cell treatment for spinal cord injury concerns scientists. Nature 2019; 565: 544-545
• 65 Damaser MS, Sievert KD. Reviving regenerative urology. Nat Rev Urol 2019; 16: 143-144
• 66 Stölting MN, Hefermehl LJ, Tremp M. et al. The role of donor age and gender in the success of human muscle precursor cell transplantation. J Tissue Eng Regen Med 2017; 11: 447-458
• 67 Feil G, Maurer S, Nagele U. et al. [Bioartificial urothelium generated from bladder washings. A future therapeutic option for reconstructive surgery]. Urologe A 2008; 47: 1091-1092 1094–1096